The prognostic value of P-cadherin in non-muscle-invasive bladder cancer

European Journal of Surgical Oncology

Volumn 40, Issue 3, 2014, Pages 255-259

  Wang, P ^a   Lin, S L ^a   Zhang, L H ^a   Li, Z ^a   Liu, Q ^a   Gao, J X ^a   Liu, D M ^a   Bo, J J ^a   Huang, Y R ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Non muscle invasive bladder cancer; P cadherin; Progression; Recurrence

Indexed keywords

NON-MUSCLE-INVASIVE BLADDER CANCER; P-CADHERIN; PROGRESSION; RECURRENCE;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CADHERINS; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84893979537     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.12.018     Document Type: Article

References (23)

1. A. Jemal, F. Bray, and M.M. Center et al. Global cancer statistics CA Cancer J Clin 61 2 2011 69 90
2. M. Babjuk, W. Oosterlinck, and R. Sylvester et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update Eur Urol 59 6 2011 997 1008
3. R.J. Sylvester, A.P. van der Meijden, and W. Oosterlinck et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 3 2006 466 475
4. B.W. van Rhijn, M. Burger, and Y. Lotan et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy Eur Urol 56 3 2009 430 442
5. P. Hulpiau, and F. van Roy Molecular evolution of the cadherin superfamily Int J Biochem Cell Biol 41 2 2009 349 369
6. M.P. Stemmler Cadherins in development and cancer Mol Biosyst 4 8 2008 835 850
7. G. Turashvili, S.E. McKinney, and O. Goktepe et al. P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer Mod Pathol 24 1 2011 64 81
8. M.A. Kim, E.J. Jung, and H.S. Lee et al. P-cadherin expression in gastric carcinoma: its regulation mechanism and prognostic significance Hum Pathol 41 6 2010 877 885
9. L. Sun, H. Hu, and L. Peng et al. P-cadherin promotes liver metastasis and is associated with poor prognosis in colon cancer Am J Pathol 179 1 2011 380 390
10. M.D. Pacifico, R. Grover, and P.I. Richman et al. Identification of P-cadherin in primary melanoma using a tissue microarrayer: prognostic implications in a patient cohort with long-term follow up Ann Plast Surg 55 3 2005 316 320
11. L. Lo Muzio, G. Campisi, and A. Farina et al. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study BMC Cancer 5 2005 63
12. L. Vlahova, Y. Doerflinger, and R. Houben et al. P-cadherin expression in Merkel cell carcinomas is associated with prolonged recurrence-free survival Br J Dermatol 166 5 2012 1043 1052
13. A. Mialhe, G. Levacher, and P. Champelovier et al. Expression of E-, P-, n-cadherins and catenins in human bladder carcinoma cell lines J Urol 164 3 Pt 1 2000 826 835
14. K.M. Rieger-Christ, J.W. Cain, and J.W. Braasch et al. Expression of classic cadherins type I in urothelial neoplastic progression Hum Pathol 32 1 2001 18 23
15. R.T. Bryan, P.A. Atherfold, and Y. Yeo et al. Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies J Pathol 215 2 2008 184 194
16. J.A. Mandeville, B. Silva Neto, and A.J. Vanni et al. P-cadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells BJU Int 102 11 2008 1707 1714
17. T. Jäger, M. Becker, and A. Eisenhardt et al. The prognostic value of cadherin switch in bladder cancer Oncol Rep 23 4 2010 1125 1132
18. V. Van Marck, C. Stove, and K. Jacobs et al. P-cadherin in adhesion and invasion: opposite roles in colon and bladder carcinoma Int J Cancer 128 5 2011 1031 1044
19. R.T. Bryan, and C. Tselepis Cadherin switching and bladder cancer J Urol 184 2 2010 423 431
20. R.R. Byrne, S.F. Shariat, and R. Brown et al. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup J Urol 165 5 2001 1473 1479
21. A. Mahnken, I. Kausch, and A.C. Feller et al. E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder Oncol Rep 14 4 2005 1065 1070
22. I. Lascombe, A. Clairotte, and S. Fauconnet et al. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors Clin Cancer Res 12 9 2006 2780 2787
23. M. Muramaki, H. Miyake, and T. Terakawa et al. Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resection Urol Oncol 30 2 2012 161 166